The results of the differential expression analysis indicate that USP30-AS1 exhibits differential expression across multiple cancer cohorts, except for uterine carcinosarcoma (UCS), pheochromocytoma and paraganglioma (PCPG), adrenocortical carcinoma (ACC), and kidney chromophobe (KICH). This evidence concerns the gene USP30 and uterine carcinosarcoma.